← All stocks

Nexalin Technology, Inc.

NXL Net buying

CIK 0001527352 #5337 in the set updated 22 Sep 2026

Bought (120 mo)

$239.43K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$239.43K

+$239.43K against sales at will

By person

9 insiders · 18 transactions

2.1×

Mark White holds only 2.1 times base salary in stock. $637.18K of shares against $300.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Mark White last reported holding, valued at $2.20, the price Common Stock was last bought or sold at on the open market here, on 12 Mar 2025.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Elson Marilyn

10% owner

$160.04K (2)

—

+$160.04K

2,370,488

10.76%

$5.22M

+45.9%

Owens David

Chief Medical Officer

$35.07K (12)

—

+$35.07K

191,252

0.8679%

$420.75K

+37.9%

Shelton Carolyn Hamby

Sr. VP - Quality - Regulatory

$13.20K (1)

—

+$13.20K

30,000

0.1361%

$66.00K

+25.0%

Kazden Alan

Director

$10.38K (1)

—

+$10.38K

119,590

0.5427%

$263.10K

+48.3%

Morad Rick

Director

$10.38K (1)

—

+$10.38K

107,989

0.4900%

$237.58K

+2.4%

White Mark

CEO

$10.38K (1)

—

+$10.38K

289,627

1.31%

$637.18K

+0.9%

OSSER LEONARD

10% owner

—

1,618,577

7.35%

$3.56M

+5.4%

Hu Ben

Director

—

377,095

1.71%

$829.61K

+127.7%

Bernhard Leslie

Director

—

49,838

0.2262%

$109.64K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 39

Amendments (4/A) skipped 6

Filings about a different issuer 0

Unreadable filings 0

Joint filings 7

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 1,117,548

History held since 20 Sep 2022